Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Journey Medical CorpDERM · Entity 6273 | Chief Operating Officer | April 22, 2026 | April 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Journey Medical Corp
Report date April 22, 2026 · Filed April 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.0001 par valueSEC Table I · non-derivative | Direct | 598,543 |
Reported balance
After 2026-04-22 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-04-22 · Grant · Acquired 46,863 · Balance 598,543 F1: On April 22, 2026, the reporting person was granted 46,863 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 15,621 shares on April 22, 2027, 15,621 shares on April 22, 2028 and 15,621 shares on April 22, 2029. F2: Includes restricted stock units, which vest over various time periods. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.04 · Expires 2036-04-22 | Direct | 62,795 |
Reported balance
After 2026-04-22 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-04-22 · Grant · Acquired 62,795 · Balance 62,795 F3: On April 22, 2026, the reporting person was granted 62,795 stock options pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 20,932 shares on April 22, 2027, 20,932 shares on April 22, 2028 and 20,931 shares on April 22, 2029. |
Filing footnotes · ownership attribution and instrument terms
F1: On April 22, 2026, the reporting person was granted 46,863 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 15,621 shares on April 22, 2027, 15,621 shares on April 22, 2028 and 15,621 shares on April 22, 2029.
F2: Includes restricted stock units, which vest over various time periods.
F3: On April 22, 2026, the reporting person was granted 62,795 stock options pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 20,932 shares on April 22, 2027, 20,932 shares on April 22, 2028 and 20,931 shares on April 22, 2029.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 22, 2026 Filed Apr 24, 2026 21:29 UTC | Journey Medical Corp DERM · Entity 6273 | GrantStock Option (Right to Buy) · Derivative | 62,795 | $0.00 Strike: $5.04 | $0.00 |
DisclosureSEC source: 0001104659-26-048736 · tm2612721-3_4seq1.xml · derivative · entry 2 Alloush Ramsey · CIK 0002061883 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,795 Underlying: Common Stock, $0.0001 par value · 62,795 shares Expires 2036-04-22 F3 · derivative.exercise_date: On April 22, 2026, the reporting person was granted 62,795 stock options pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 20,932 shares on April 22, 2027, 20,932 shares on April 22, 2028 and 20,931 shares on April 22, 2029. Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 21:29 UTC | Journey Medical Corp DERM · Entity 6273 | GrantCommon Stock, $0.0001 par value | 46,863 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-048736 · tm2612721-3_4seq1.xml · nonDerivative · entry 1 Alloush Ramsey · CIK 0002061883 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 598,543 F1 · shares: On April 22, 2026, the reporting person was granted 46,863 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 15,621 shares on April 22, 2027, 15,621 shares on April 22, 2028 and 15,621 shares on April 22, 2029. F2 · balance_after: Includes restricted stock units, which vest over various time periods. Read SEC document |
| June 17, 2025 Filed Jun 20, 2025 20:06 UTC | Journey Medical Corp DERM · Entity 6273 | GrantStock Option (Right to Buy) · Derivative | 62,795 | $0.00 Strike: $6.31 | $0.00 |
DisclosureSEC source: 0001104659-25-061156 · tm2518547-3_4seq1.xml · derivative · entry 2 Alloush Ramsey · CIK 0002061883 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,795 Underlying: Common Stock, $0.0001 par value · 62,795 shares Expires 2035-06-17 F3 · derivative.exercise_date: On June 17, 2025, the reporting person was granted 62,795 stock options pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 20,932 shares on January 1, 2026, 20,932 shares on January 1, 2027 and 20,931 shares on January 1, 2028. Read SEC document |
| June 17, 2025 Filed Jun 20, 2025 20:06 UTC | Journey Medical Corp DERM · Entity 6273 | GrantCommon Stock, $0.0001 par value | 46,863 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-061156 · tm2518547-3_4seq1.xml · nonDerivative · entry 1 Alloush Ramsey · CIK 0002061883 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 551,680 F1 · shares: On June 17, 2025, the reporting person was granted 46,863 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 15,621 shares on January 1, 2026, 15,621 shares on January 1, 2027 and 15,621 shares on January 1, 2028. F2 · balance_after: Includes restricted stock units, which vest over various time periods. Read SEC document |
| May 02, 2025 Filed May 5, 2025 21:31 UTC | Journey Medical Corp DERM · Entity 6273 | SaleCommon Stock, $0.0001 par value | 2,857 | $6.84 | $19,541.88 |
DisclosureSEC source: 0001104659-25-044606 · tm2514029-1_4seq1.xml · nonDerivative · entry 1 Alloush Ramsey · CIK 0002061883 · COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 504,817 F1 · shares: In connection with the vesting of restricted stock units which vested as of various dates, a total of 2,857 of the underlying shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock units. F2 · price: Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on May 2, 2025, was $6.73 to $7.05. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes restricted stock units, which vest over various time periods. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.